| KLAR Stock | | | SEK 0.40 0.02 5.26% |
Executive
Ms. Susan Suchdev serves as Chief Operating Officer at Klaria Pharma Holding AB . She holds MS, Karolinska Institute and Stockholm University, Nutrition and Clinical Development. She has previously been Head Nordic Reg. Affairs, Nestle Country Manager, IRW Unit Manager, TFS Clinical Research, Pfizer AB.
| Age | 51 |
| Phone | 46 84 46 42 99 |
| Web | https://www.klaria.com |
Klaria Pharma Management Efficiency
The company has return on total asset
(ROA) of
(0.2915) % which means that it has lost $0.2915 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.8766) %, meaning that it generated substantial loss on money invested by shareholders. Klaria Pharma's management efficiency ratios could be used to measure how well Klaria Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Klaria Pharma Holding has accumulated 1.02
M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity.
Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden. Klaria Pharma Holding (KLAR) is traded on Stockholm Exchange in Sweden and employs 6 people.
Management Performance
Klaria Pharma Holding Leadership Team
Elected by the shareholders, the Klaria Pharma's board of directors comprises two types of representatives: Klaria Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Klaria. The board's role is to monitor Klaria Pharma's management team and ensure that shareholders' interests are well served. Klaria Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Klaria Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Klaria Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Klaria Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to
measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to
predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.